thrombin
n. [生化] 凝血酶
2025-09-09 14:51 浏览次数 11
n. [生化] 凝血酶
thrombin inhibitor凝血酶抑制体
thrombin potential凝血酶潜势
thrombin activation凝血酶活化的
Thrombin Porcine猪凝血酶
thrombin topical翻译
thrombin zymogen凝血酶原
Thrombin Bovine牛凝血酶
thrombin injection凝血酶注射
thrombin receptorThere are three known thrombin receptors termed PAR1, PAR3 and PAR4 (PAR for protease-activated receptor).
objective:to study clinical value of radiocystitis therapy with thrombin intra-bladder perfusion.
目的:探讨凝血酶膀胱灌注治疗放射性膀胱炎的临床应用价值。
aim to investigate the apoptotic effect of thrombin on brain microvascular endothelial cell(bmvec) of cultured rat, and the protective effect of hirudin, an inhibitor of thrombin.
目的探讨凝血酶对体外培养的原代大鼠脑微血管内皮细胞(bmvec)的损伤作用及凝血酶抑制剂水蛭素的保护作用。
objective:to observate the effects of thrombin and ranitidine for new-born hemorrhage of upper digestive tract.
潘目的:为了解凝血酶与雷尼替丁在新生儿上消化道出血的疗效。
the results also showed that the inhibition of plasmic thrombin formation in various dosage groups was positively correlate with the injected dose.
与此同时,各剂量组的血浆凝血酶生成也固定受到抑制,受抑制程度与给予剂量呈正相关。
the article reviews the general characteristics of thrombin and its neurotoxic effects.
文章就凝血酶的一般特性和其神经毒性作用作了综述。
result the thrombin time was distinctly shortened(p0.01) after the ions joining into the extraction.
结果加入无机阳离子后,明显缩短了全蝎的凝血酶时间(p0.01)。
small dose thrombin group(iu).
小剂量凝血酶组;
irreversible inhibitor of thrombin and other serine proteases. inhibits by acylation of the active site of the enzyme. much less toxic than pmsf and dfp.
凝血酶及其他丝氨酸蛋白酶的不可逆抑制剂,将活性位点酰基化。比pmsf和dfp毒性小得多。
thrombin converts protein c into activated protein c(apc).
凝血酶能将蛋白c转化为活化蛋白c(apc);
conclusion: s / d does not influence human thrombin activity and ion-exchange chromatography can remove s / d in blood products to make the products safe and reliable.
结论,s/d对人凝血酶活性无影响,采用离子交换层析法能去除血液制品中的s/d,使产品达到安全可靠。
objective:to study the effects of combination of quercetin monosulfate and 5「 chloro 5」 deoxyadenosine on platelet aggregation induced by thrombin in rabbits.
目的:研究槲皮素单硫酸酯和5’-氯-5’-脱氧腺苷合用对凝血酶诱导兔血小板聚集的影响。
conclusion:the kinetic measurement for thrombin generation could become a new trend for coagulative function evaluation because of its utility and feasibility.
结论:凝血酶生成动力学检查方法可行实用,有望成为评价人体凝血功能检查方法的一种新趋势。
objective to evaluate the feasibility and safety of ultrasound-localized percutaneous thrombin injection (ulti) for the treatment of iatrogenic femoral pseudoaneurysm.
目的探讨瘤腔内注射凝血酶治疗股动脉假性动脉瘤的安全性和可行性。
thrombin in blood is a new haemostatic which is exploited in recent years.
血浆中凝血酶是近年开发的一种新型止血剂。
conclusion the therapeutic effect of false arteria femoralis by using compression method and injecting thrombin into aneurysm cavity by color doppler ultrasonic guidance is therapeutical and safe.
结论在彩色多普勒超声引导下运用压迫法结合瘤腔内注射凝血酶治疗假性股动脉瘤的方法是安全有效的。
objective:to evaluate the effects of pseudoaneurysm treated by compression and repair, thrombin injection, embolization and surgical procedure.
前言:目的:评价压迫修复、注射凝血酶、栓塞及手术治疗方法对假性动脉瘤的治疗效果。
pa form, size, neck length and width, thrombin dose, therapic effect and complications were analysed.
分析pa的形状、大小、颈部长度与宽度、凝血酶剂量、治疗结果以及并发癥。
the ultimate result is the formation of the thrombin and fibrin clot, and each enzymolysis accompaniment magnify effective.
最终结果是凝血酶和纤维蛋白凝块的形成,而且每步酶解反应均有放大效应。